Compounds > 9-aminocamptothecin
Page last updated: 2024-08-25

9-aminocamptothecin and Experimental Mammary Neoplasms

9-aminocamptothecin has been researched along with Experimental Mammary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirichenko, AV; Rich, TA; Travis, EL1
Kirichenko, AV; Newman, RA; Rich, TA; Travis, EL1

Other Studies

2 other study(ies) available for 9-aminocamptothecin and Experimental Mammary Neoplasms

ArticleYear
Radiation enhancement by 9-aminocamptothecin. Evidence for improved therapeutic ratio with a multiple dose schedule.
    Annals of the New York Academy of Sciences, 1996, Dec-13, Volume: 803

    Topics: Animals; Camptothecin; Combined Modality Therapy; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H

1996
Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Cancer research, 1997, May-15, Volume: 57, Issue:10

    Topics: Animals; Antineoplastic Agents; Camptothecin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Radiation-Sensitizing Agents

1997